Duration of chronic kidney disease reduces attention and executive function in pediatric patients

Susan R Mendley, Matthew B Matheson, Shlomo Shinnar, Marc B Lande, Arlene C Gerson, Robert W Butler, Bradley A Warady, Susan L Furth, Stephen R Hooper, Susan R Mendley, Matthew B Matheson, Shlomo Shinnar, Marc B Lande, Arlene C Gerson, Robert W Butler, Bradley A Warady, Susan L Furth, Stephen R Hooper

Abstract

Chronic kidney disease (CKD) in childhood is associated with neurocognitive deficits. Affected children show worse performance on tests of intelligence than their unaffected siblings and skew toward the lower end of the normal range. Here we further assessed this association in 340 pediatric patients (ages 6-21) with mild-moderate CKD in the Chronic Kidney Disease in Childhood cohort from 48 pediatric centers in North America. Participants underwent a battery of age-appropriate tests including Conners' Continuous Performance Test-II (CPT-II), Delis-Kaplan Executive Function System Tower task, and the Digit Span Backward task from the age-appropriate Wechsler Intelligence Scale. Test performance was compared across the range of estimated glomerular filtration rate and duration of CKD with relevant covariates including maternal education, household income, IQ, blood pressure, and preterm birth. Among the 340 patients, 35% had poor performance (below the mean by 1.5 or more standard deviations) on at least one test of executive function. By univariate nonparametric comparison and multiple logistic regression, longer duration of CKD was associated with increased odds ratio for poor performance on the CPT-II Errors of Commission, a test of attention regulation and inhibitory control. Thus, in a population with mild-to-moderate CKD, the duration of disease rather than estimated glomerular filtration rate was associated with impaired attention regulation and inhibitory control.

References

    1. Hailpern SM, Melamed MM, Cohen HW, et al. Moderate chronic kidney disease and cognitive function in adults 20 to 59 Years of Age: Third National Health and Nutrition Examination Survey (NHANES III) J Am Soc Nephrol. 2007;18:2205–2213.
    1. Tamura MK, Wadley V, Yaffe K, et al. Kidney function and cognitive impairment in US adults: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Kidney Dis. 2008;52:227–234.
    1. Tamura MK, Dawei X, Yaffe K, et al. Vascular risk factors and cognitive impairment in chronic kidney disease: The Chronic Renal Insufficiency Cohort (CRIC) Study. Clin J Am Soc Nephrol. 2011;6:248–256.
    1. Tamura MK, Muntner P, Wadley V, et al. Albuminuria, kidney function, and the incidence of cognitive impairment among adults in the United States. Am J Kidney Dis. 2011;58(5):756–763.
    1. Joosten H, Izaks GJ, Slaets JPJ, et al. Association of cognitive function with albuminuria and eGFR in the general population. Clin J Am Soc Nephrol. 2011;6:1400–1409.
    1. Ikram MA, Vernooij MW, Hofman A, et al. Kidney function is related to cerebral small vessel disease. Stroke. 2008;39:55–61.
    1. Seliger SL, Longstreth WT, Jr, Katz R, et al. Cystatin C and subclinical brain infarction. J Am Soc Nephrol. 2005;16:3721–3727.
    1. Kobayashi S, Ikeda T, Moriya H, et al. Asymptomatic cerebral lacunae in patients with chronic kidney disease. Am J Kidney Dis. 2004;44:35–41.
    1. Gerson AC, Butler R, Moxey-Mims M, et al. Neurocognitive outcomes in children with chronic kidney disease: current findings and contemporary endeavors. Ment Retard Dev Disabil Res. 2006;12(3):208–215.
    1. Gipson DS, Duquette PJ, Icard PF, et al. The central nervous system in childhood chronic kidney disease. Pediatr Nephrol. 2007;22(10):1703–10.
    1. Rotundo A, Nevins TE, Lipton M, et al. Progressive encephalopathy in children with chronic renal insufficiency in infancy. Kidney Int. 1982;21(3):486–91.
    1. McGraw ME, Haka-Ikse K. Neurologic-developmental sequelae of chronic renalfailure in infancy. J Pediatr. 1985;106(4):579–83.
    1. Polinsky MS, Kaiser BA, Stover JB. Neurologic development of children with severe chronic renal failure from infancy. Pediatr Nephrol. 1987;1:157–165.
    1. Fennell RS, Fennell EB, Carter RL, et al. A longitudinal study of the cognitive function of children with renal failure. Pediatr Nephrol. 1990;4:11–15.
    1. Elzouki A, Carroll J, Butinar DI, et al. Improved neurological outcome in children with chronic renal disease from infancy. Pediatr Nephrol. 1994;8(2):205–10.
    1. Qvist E, Pihko H, Fagerudd P, et al. Neurodevelopmental outcome in high-risk patients after renal transplantation in early childhood. Pediatr Transplant. 2002;6:53–62.
    1. Schnaper HW, Cole BR, Hodges FJ, et al. Cerebral cortical atrophy in pediatric patients with end-stage renal disease. Am J Kidney Dis. 1983;2:645–650.
    1. Steinberg A, Efrat R, Pomeranz A, et al. Computerized tomography of the brain in children with chronic renal failure. Int J Pediatr Nephrol. 1985;6:121–126.
    1. Valanne L, Qvist E, Jalanko H, et al. Neuroradiologic findings in children with renal transplantation under 5 years of age. Pediatr Transplant. 2004;8:44–51.
    1. Warady BA, Belden B, Kohaut E. Neurodevelopmental outcome of children initiating peritoneal dialysis in early infancy. Pediatr Nephrol. 1999;13:759–65.
    1. Warady BA. Neurodevelopment of infants with end-stage renal disease: is it improving? Pediatr Transplant. 2002 Feb;6:5–7.
    1. Brouhard BH, Donaldson LA, Lawry KW, et al. Cognitive functioning in children on dialysis and post-transplantation. Pediatr Transplant. 2000;4:261–7.
    1. Mendley SR, Zelko F. Improvement in specific aspects of neurocognitive performance in children after renal transplantation. Kidney Int. 1999;56:318–323.
    1. Icard P, Hooper SR, Gipson DS, et al. Cognitive improvement in children with CKD after transplant. Pediatr Transplant. 2010;14:887–90.
    1. Lawry KW, Brouhard BH, Cunningham RJ. Cognitive functioning and school performance in children with renal failure. Pediatr Nephro. 1994;8:326–9.
    1. Brunner HI, Ruth NM, German A, et al. Initial validation of the Pediatric Automated Neuropsychological Assessment Metrics for childhood-onset systemic lupus erythematosus. Arthritis Rheum. 2007 Oct 15;57(7):1174–82.
    1. Muscal E, Bloom DR, Hunter JV, Myones BL. Neurocognitive deficits and neuroimaging abnormalities are prevalent in children with lupus: clinical and research experiences at a US pediatric institution. Lupus. 2010 Mar;19(3):268–79.
    1. Williams TS, Aranow C, Ross GS, et al. Neurocognitive impairment in childhood-onset systemic lupus erythematosus: measurement issues in diagnosis. Arthritis Care Res. 2011 Aug;63(8):1178–87.
    1. Feldmann R, Weglage J, Roth J, et al. Systemic juvenile rheumatoid arthritis: cognitive function and social adjustment. Ann Neurol. 2005 Oct;58(4):605–9.
    1. Castaneda AE, Tuulio-Henriksson A, Aronen ET, et al. Cognitive functioning and depressive symptoms in adolescents with inflammatory bowel disease. World J Gastroenterol. 2013 Mar 14;19(10):1611–7.
    1. Buizer AI, de Sonneville LM, Veerman AJ. Effects of chemotherapy on neurocognitive function in children with acute lymphoblastic leukemia: a critical review of the literature. Pediatr Blood Cancer. 2009 Apr;52(4):447–54.
    1. Hooper SR, Gerson AC, Butler RW, et al. Neurocognitive functioning of children and adolescents with mild-to-moderate chronic kidney disease. Clin J Am Soc Nephrol. 2011;6:1824–30.
    1. McCabe DP, Roediger HL, McDaniel MA, et al. The relationship between working memory capacity and executive functioning: evidence for a common executive attention construct. Neuropsych. 2010;24:222–43.
    1. Wu K, Chan S, Leung P, et al. Components and Developmental Differences of Executive Functioning for School-Aged Children. Dev Neuropsych. 2011;36:319–337.
    1. Jefferson AL, Paul RH, Ozonoff A, et al. Evaluating elements of executive functioning as predictors of instrumental activities of daily living (IADLs) Arch Clin Neuropsychol. 2006;21(4):311–320.
    1. Carlson SM, Moses LJ, Claxton LJ. Individual differences in executive functioning and theory of mind: An investigation of inhibitory control planning ability. J Exp Child Psychol. 2004;87(4):299–319.
    1. Lyon GR, Krasnegor NA, editors. Attention, memory, and executive function. Paul H. Brookes Publishing Company; Baltimore: 1996.
    1. Zelazo PD, Muller U. The Wiley-Blackwell Handbook of Childhood Cognitive Development. 2. Chapter 22 Goswami U. Blackwell; Oxford, UK: 2010. Executive function in typical and atypical development.
    1. Pennington B. Dimensions of executive functions in normal and abnormal development. In: Krasnegor NA, Lyon GR, Goldman-Rakic PS, Paul H, editors. Development of Prefrontal Cortex. Brookes Publishing Company; Baltimore: 1997. pp. 265–281.
    1. Welsh MC, Pennington BF, Groisser DB. A normative developmental study of executive function: A window on the prefrontal function in children. Developmental Neuropsychology. 1991;7:131–149.
    1. Korkman M, Kemp SL, Kirk U. Effects of age on neurocognitive measures of children ages 5 to 12: A cross-sectional study on 800 children from the United States. Dev Neuropsychol. 2001;20(1):331–354.
    1. Horton AM, Jr, Soper HV, Reynolds CR. Executive functions in children with traumatic brain injury. Appl Neuropsychol. 2010;17(2):99–103.
    1. Gipson DS, Hooper SR, Duquette PJ, et al. Memory and executive functions in pediatric chronic kidney disease. Child Neuropsychol. 2006;12:391–405.
    1. Gerson AC, Wentz A, Abraham AG, Mendley SR, Hooper SR, Butler RW, Gipson DS, Lande MB, Shinnar S, Moxey-Mims MM, Warady BA, Furth SL. Health-related quality of life of children with mild to moderate chronic kidney disease. Pediatrics. 2010 Feb;125(2):e349–57.
    1. Lande MB, Gerson AC, Hooper SR, et al. Casual blood pressure and neurocognitive function in children with chronic kidney disease: a report of the children with chronic kidney disease cohort study. Clin J Am Soc Nephrol. 2011;6:1831–7.
    1. Fennell EB, Fennell RS, Mings E, et al. The effects of various modes of therapy for end stage renal disease on cognitive performance in a pediatric population--a preliminary report. Int J Pediatr Nephrol. 1986;7:107–12.
    1. Dennis M, Francis DJ, Cirino PT, Schachar R, Barnes MA, Fletcher JM. Why IQ is not a covariate in cognitive studies of neurodevelopmental disorders. J Int Neuropsychol Soc. 2009;15:331–343.
    1. Furth SL, Cole SR, Moxey-Mims M, et al. Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study. Clin J Am Soc Nephrol. 2006;1:1006–15.
    1. Schwartz GJ, Furth S, Cole SR, et al. Glomerular filtration rate via plasma iohexol disappearance: pilot study for chronic kidney disease in children. Kidney Int. 2006;69:2070–7.
    1. Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009;20:629–37.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel